Andres Ricaurte Fajardo, Molecular Imaging and Theranostics Researcher at Weil Cornell Medicine, shared a post on X:
“Thrilled to be part of this study highlighting how dural-based metastases rare yet significant in prostate cancer can be distinguished from meningioma, using Prostate-Specific Membrane Antigen Positron Emission Tomography (PSMA PET). This underscores the value of targeted PET in Prostate Cancer.
Congratulations Divya Yadav, Jana Ivanidze.”
PSMA PET improves characterization of dural-based intracranial lesions in patients with metastatic prostate cancer published in ScienceDirect.
